摘要
目的研究当下心血管内科非瓣膜性心房颤动患者住院抗凝治疗情况。方法随机选取2017年1月—2018年6月该院心内科收治的100例非瓣膜性心房颤动住院患者,收集患者临床基础信息资料、用药方案以及抗凝治疗监测状况,药物治疗方案与INR状况等。结果 100例非瓣膜性心房颤动住院患者中抗凝治疗率26.00%。华法林抗凝治疗住院期间INR达标9例(9.00%);医生处方抗凝药物影响因素主要包括出血史、脑卒中史冠心病以及年龄等。结论非瓣膜性心房颤动住院患者需采用抗凝治疗,新型口服抗凝药物临床未广泛应用,华法林抗凝治疗患者INR达标率偏低。
Objective To investigate the status of hospitalized anticoagulant therapy in patients with non-valvular atrial fibrillation. Methods 100 patients with non-valvular atrial fibrillation admitted to our hospital from January 2017 to June2018 was randomly selected and conducted. The clinical basic information, medication regimen, and anticoagulant therapy status, drug treatment plan and INR were collected. Results The rate of anticoagulant therapy in 100 patients with nonvalvular atrial fibrillation was 26.00%. Warfarin anticoagulant therapy during the hospitalization of INR reached 9 cases(9.00%);doctors prescription anticoagulant drugs mainly include bleeding history, stroke history of coronary heart disease and age. Conclusion Patients with non-valvular atrial fibrillation need anticoagulant therapy. The new oral anticoagulant drugs have not been widely used in clinical practice. The INR compliance rate of warfarin anticoagulant therapy patients is low.
作者
张新莲
ZHANG Xin-lian(Department of Cardiology, Kuche County People's Hospital, Kuche, Xinjiang, 842000 China)
出处
《中外医疗》
2019年第7期93-95,共3页
China & Foreign Medical Treatment
关键词
心血管内科
非瓣膜性心房颤动
住院
抗栓治疗
Cardiovascular medicine
Non-valvular atrial fibrillation
Hospitalization
Antithrombotic therapy
